Please login to the form below
Farmindustria
This page shows the latest Farmindustria news and features for those working in and with pharma, biotech and healthcare.
Planning overhaul
FarmIndustria move sends marketers back to the drawing board. Pharmaceutical companies in Italy have learned that they will be unable to pay the travel expenses of doctors attending meetings or congresses ... The decision by Italian industry association
Latest news
-
Let's talk about it
These themes are currently being debated in Italy and represent one of FarmIndustria's top priorities. ... The Author. Sergio DompÈ is president of the Italian pharmaceutical industry association, FarmIndustria.
More from news
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest Intelligence
-
Current development and marketing of biosimilar monoclonal antibodies in Latin America
Western Pharmaceutical (Ecuador). (2). Farmindustria (Peru). (2). FAPASA (Paraguay). Probiomed. Mexico. ... 1) Filed also in Colombia and rejected twice during 2012. (2) Western Pharmaceutical and Farmindustria are subsidiaries of CF Recalcine.
-
Partial privatisation shakes up pharma market in Spain
The cost-containment policies have boosted the generics market by volume and according to Farmindustria sales of prescription medicines have been falling.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Biogen and Happify Health team up to create digital platform for MS patients
- Moderna to launch Innovation and Technology Center in the UK
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Live Webinar: Navigating the Nuances of Europe's MedTech Industry
- Why project managers are key to creating quality content
- Pfizer and BioNTech sign $3.2bn COVID-19 vaccine supply agreement with US government
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- NICE issues final appraisal recommending LEO Pharma’s Adtralza for moderate-to-severe atopic dermatitis
- ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
- A creative awakening – how pharma is bringing innovation to the patient journey
- AstraZeneca’s Evusheld phase 3 results show high level of protection against COVID-19
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- Novartis endorses Kigali Declaration by investing $250m for tropical diseases
- Pfizer, Mylan move ahead with generics merger and spin-out
PMHub
Origins Insights
Origins are part of the Resonant Group. Using novel research methodologies, we dig deeper to deliver authentic audience experiences that...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
